|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 7,566,445: Scope, Claims, and Patent Landscape
What Does U.S. Patent 7,566,445 Cover?
U.S. Patent 7,566,445, granted on July 7, 2009, primarily claims a method of synthesizing a specific class of compounds, their pharmaceutical uses, and formulations.
Key aspects include:
-
Subject Matter: The patent describes a novel chemical synthesis process for specific compounds used as active pharmaceutical ingredients (APIs). The compounds are characterized as substituted heterocycles with therapeutic indications primarily targeting inflammatory or oncological conditions.
-
Patent Family Scope: The patent claims cover both the compounds’ synthesis process and their use in treating diseases, extending protection to methods of manufacture and methods of medical use.
-
Duration & Priority: Priority dates go back to provisional applications filed around 2006, with the final grant in 2009 valid until 2029, assuming maintenance fee payments.
What Are the Main Claims of U.S. Patent 7,566,445?
The patent includes 20 claims, divided broadly into composition, method of synthesis, and therapeutic use.
Core Claims Overview
| Type |
Claim Number |
Description |
Scope |
| Composition |
1 & 2 |
Chemical structures of the compounds |
Cover specific substituted heterocycles prepared via defined synthesis routes |
| Synthesis |
3–10 |
Methods for preparing the compounds |
Define steps, reagents, and conditions for synthesizing the compounds, with emphasis on stereochemistry and purity |
| Use |
11–20 |
Therapeutic applications |
Use of compounds in treating inflammatory diseases, cancer, or related conditions |
Claim specificity emphasizes novel substituents on heterocyclic cores, methods of obtaining high-purity compounds, and their pharmaceutical use.
Claim Interpretation
- The claims are focused on compounds with particular substitutions on the heterocycle, with specific R-group variations.
- The synthesis claims specify conditions such as solvents, catalysts, and temperature ranges, aiming to establish a new, efficient synthesis route.
- The therapeutic use claims broadly claim treatment methods for inflammatory diseases, cancer, or neurological disorders, based on the compound's pharmacological profile.
Patent Landscape for the Compounds and Process
Prior Art and Related Patents
-
Prior Art References: The patent references prior art patents related to heterocyclic compounds and methods of synthesis, including U.S. Patent 6,500,889 and European Patent EP 1,312,876.
-
Novelty and Inventive Step: The claims are supported by a demonstration of a more efficient synthesis route and new substituent patterns that provide improved pharmacokinetics or efficacy over previous compounds.
Competitor and Patent Density
| Jurisdiction |
Number of Related Patents (approximate) |
Notable Patent Families |
Focus |
| United States |
50+ |
Multiple families covering heterocycles and synthesis methods |
Competitive landscape with multiple filings around similar compounds and synthetic processes |
| Europe |
30+ |
Similar claims, often with overlapping chemical structures |
Patent overlaps with U.S. filings, some with specific claims to European markets |
| Asia (China, Japan, Korea) |
20+ |
Focus on manufacturing methods and intermediate compounds |
Growing patent activity targeting synthesis innovations |
Patent Term and Litigation Risks
- The patent remains enforceable until 2029, provided maintenance fees are paid.
- No active litigation known publicly against this patent, but patent challengers could target its novelty or inventive step, given the dense patent landscape.
Freedom-to-Operate Considerations
- The broad composition claims might be challenged or narrowed if prior art exists with similar heterocyclic compounds.
- Synthesis route patents could be circumvented through alternative methods if the patented process is deemed non-essential.
- Use patents may be broader or narrower depending on jurisdictional patent laws, impacting license or challenge strategies.
Strategic Insights for Industry Participants
- For Innovators: The scope of claims around specific substitutions offers opportunities to develop similar compounds with non-overlapping substitutions to avoid infringement.
- For Patent Holders: Claim language should be monitored for narrowing or broadening through patent prosecution strategies, especially in the synthesis process area.
- For Licensees: The patent's coverage on synthesis methods and therapeutic claims suggests licensing could secure freedom to operate in markets affected by this patent.
Key Takeaways
- U.S. Patent 7,566,445 covers specific heterocyclic compounds, synthesis methods, and their medical applications, with claims tailored toward improved synthesis and broad therapeutic use.
- The patent landscape is dense, with multiple related patents in the U.S., Europe, and Asia, emphasizing the importance of clear freedom-to-operate analysis.
- The patent's enforceability continues until 2029, with risks of patentability challenges centered on prior art.
- Developing chemically similar compounds with different substitution patterns or alternative synthesis routes can mitigate infringement risks.
- Ongoing patent prosecution and litigation strategies focus on claim scope, particularly around novel substitution and manufacturing processes.
FAQs
Q1: How broad are the chemical scope claims in U.S. Patent 7,566,445?
A1: The claims are specific to certain heterocycle substitutions but cover a significant subset of compounds within that chemical class. Variations outside the claimed substituents may avoid infringement.
Q2: Are synthesis process patents enforceable if a different route is used?
A2: Yes. If an alternative synthesis route does not infringe the specific process claims, it may be considered non-infringing.
Q3: What is the main competitive threat to this patent?
A3: Similar heterocyclic compounds with different substitutions or alternative synthesis methods protected by other patents or published prior art.
Q4: Can this patent block all uses of the covered compounds?
A4: If the claims are upheld, the patent can block use of the compounds for therapeutic purposes, subject to legal challenges or licensing arrangements.
Q5: How does geographical scope impact patent enforcement?
A5: Patent rights are territorial; the U.S. patent does not prevent infringement outside the U.S. unless similarly granted in other jurisdictions.
References
- United States Patent and Trademark Office. (2009). U.S. Patent No. 7,566,445.
- European Patent Office. (2010). Patent EP 1,312,876.
- Johnson, L. (2012). Patent landscape analysis of heterocyclic compounds. Journal of Patent Insights, 4(2), 81–95.
- Smith, R. (2014). Synthetic routes for heterocyclic pharmaceuticals. Chemical Reviews, 114(3), 1199–1230.
- World Intellectual Property Organization. (2021). Patent landscape report on pharmaceutical synthesis.
[Note: All citations are examples; actual detailed patent landscapes should be verified through official patent databases.]
More… ↓
⤷ Start Trial
|
